The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.

作者信息

Lim Wendy, Vesely Sara K, George James N

机构信息

Department of Medicine, McMaster University, Hamilton, ON, Canada; and.

Department of Biostatistics and Epidemiology, College of Public Health, Department of Medicine, College of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.

出版信息

Blood. 2015 Mar 5;125(10):1526-31. doi: 10.1182/blood-2014-10-559211. Epub 2015 Jan 8.

DOI:10.1182/blood-2014-10-559211

PMID:25573992

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4351502/

Abstract

摘要

相似文献

[1]

The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.

Blood. 2015-3-5

[2]

Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.

Am J Hematol. 2012-3-9

[3]

[Aphasia and thrombocytopenic thrombotic purpura in a young woman: the platelet count dilemma].

Rev Neurol. 2013-10-1

[4]

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Blood. 2008-7-1

[5]

[Recent therapeutic strategy for thrombotic thrombocytopenic purpura].

Rinsho Ketsueki. 2014-1

[6]

Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.

Clin Adv Hematol Oncol. 2006-3

[7]

Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura.

Clin Adv Hematol Oncol. 2006-3

[8]

A case series of atypical presentations of thrombotic thrombocytopenic purpura.

J Clin Apher. 2012

[9]

Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.

Thromb Haemost. 2008-7

[10]

[Thrombotic thrombocytopenic purpura].

Rinsho Ketsueki. 2012-2

引用本文的文献

[1]

Thrombotic thrombocytopenic purpura in pregnancy: A case report and literature review.

Obstet Med. 2025-6-3

[2]

Efficacy and Safety of Rituximab in Connective Tissue Disease-Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy.

Int J Rheum Dis. 2025-6

[3]

A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.

J Clin Apher. 2025-4

[4]

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.

J Clin Med. 2024-10-31

[5]

How Should Complicated Cases of Thrombotic Thrombocytopenic Purpura With Positive Coombs Test Be Treated?

Cureus. 2023-12-18

[6]

Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience.

Int J Hematol Oncol Stem Cell Res. 2023-7-1

[7]

Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report.

Cureus. 2023-7-25

[8]

Clínica neurológica fluctuante: ¿Llamo al neurólogo o al hematólogo?

Adv Lab Med. 2020-8-17

[9]

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?

Adv Lab Med. 2020-11-12

[10]

Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura.

Blood Transfus. 2023-9

本文引用的文献

[1]

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.

Blood. 2014-5-28

[2]

Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.

J Clin Apher. 2013-12

[3]

Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases.

Hematology. 2013-7

[4]

Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.

J Thromb Haemost. 2013-3

[5]

Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature.

Blood Coagul Fibrinolysis. 2012-6

[6]

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Crit Care Med. 2012-1

[7]

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.

Blood. 2011-6-2

[8]

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.

Transfus Apher Sci. 2010-12

[9]

Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.

Pediatr Hematol Oncol. 2011-3

[10]

Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.

Ann Hematol. 2010-4-27

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献